Atypical measles after vaccination with killed vaccine

T Rød1, K W Haug, J C Ulstrup

  • 1Bacteriological/Virological Laboratory and the Pediatric Department, Ullevål Hospital, Oslo, Norway.

Insights

Two siblings vaccinated in 1963 with killed and live measles vaccines developed severe atypical measles upon natural infection in 1967. This serious illness included pneumonia and persistent lung infiltration, highlighting vaccine limitations.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pediatrics

Background:

  • The 1963 measles vaccine regimen involved two killed vaccine injections followed by one live vaccine.
  • Atypical measles presentations can occur even after vaccination.

Purpose of the Study:

  • To present two cases of atypical measles in children previously vaccinated with an early measles vaccine formulation.
  • To describe the clinical course and diagnostic findings in these atypical measles cases.

Main Methods:

  • Case study of two siblings with suspected atypical measles.
  • Epidemiological investigation of measles exposure and vaccination history.
  • Serological confirmation of measles infection.
  • Radiological examination (X-ray) for pulmonary complications.

Main Results:

  • Both siblings, vaccinated in 1963, contracted natural measles in 1967, presenting with severe illness.
  • Symptoms included high fever, exanthem, pneumonia, and prostration, with recovery within two weeks.
  • One patient exhibited persistent lung infiltration on chest X-ray.

Conclusions:

  • The presented cases represent atypical measles, consistent with descriptions by Fulginiti and Kempe.
  • Early measles vaccine formulations may not provide complete protection against severe natural infection.
  • Atypical measles following vaccination warrants further investigation regarding vaccine efficacy and long-term sequelae.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
54.7K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
67
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
146
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
62
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
18.1K
Cross-reactivity00:42

Cross-reactivity

Overview
34.1K